Shares of Trulieve Cannabis Corp TCNNF were down Monday after the Florida company reported third-quarter results.
The company, which started trading on the Canadian Securities Exchange and U.S. OTC market in September, saw higher revenue and EBITDA during the quarter.
What Happened
Trulieve's Q3 revenue of $28.3 million is higher by almost 43 percent on the year compared to the $19.8 million posted for the same period of 2017.
The company's net income under IFRS surged from $7.9 million in Q2 to $17.5 million. Trulieve's earnings before interest, taxes, depreciation, and amortization increased from $800,000 a year earlier and $11.7 million in Q2 to $12.6 million.
At the same time, the company's gross margin declined by 4.9 percentage points to 70.5 percent quarter-over-quarter, but increased from 43.9 percent a year earlier.
Why It's Important
Trulieve is one of the largest cannabis companies in Florida and is the first fully licensed medical marijuana producer and retailer that cultivates cannabis, processes and distributes it through its own branded chain of dispensaries and home deliveries in the state. The company operates 21 dispensaries.
What's Next
Trulieve recently announced plans to expand its operations outside of Florida and into other states. The company has acquired Life Essence and Leef Industries, giving it exposure to the Massachusetts and California markets.
"We believe we are well-positioned in continuing to be the dominant leader in the Florida market while firmly establishing our footprint in the Massachusetts and California markets moving forward," CEO Kim Rivers said in a statement.
Trulieve's OTC-traded shares were down 9.92 percent at $11.17 at the time of publication Monday.
Related Links:
First Recreational Cannabis Stores In Massachusetts To Open Tuesday
Cannabis Earnings Roundup: Record Sales, But Concerns Remain
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.